Anti-Infectious Drugs Products

Highlight

• Local Manufacture API ( Active Pharmaceutical ingredients )
• Generic medicine and bioequivalent to the reference medicine

Indication

For the treatment of chronic hepatitis B virus infection in adults.

Specification:

• Form: Film-coated tablets
• Strength: 0.5 mg · 1 mg
• Pack: Box, 3 blisters @ 10 film-coated tablets
• REG. BPOM: GKL2357901517A1
• Halal: ✓ Halal-certified API
• Approvals: Local API manufacture · Bioequivalent

Highlight

• Broad-spectrum antifungal (triazole class)
• Fungicidal activity against Aspergillus spp.
• Effective for severe and life-threatening fungal infections
• Option for patients intolerant or refractory to other antifungals
• Available in IV formulation (hospital setting)
• Well-established efficacy in invasive fungal infections

Indication

Invasive aspergillosis; candidemia in non-neutropenic patients; serious invasive Candida infections (incl. C. krusei); esophageal candidiasis; serious fungal infections caused by Scedosporium apiospermum and Fusarium spp.; for patients intolerant or unresponsive to other therapies.

Specification:

• Form: Powder for solution for infusion
• Strength: 200 mg
• Pack: Box, 1 Vial @ 200 mg
• REG. BPOM: DKI2564900480A1
• BPJS: Listed
• Category: Antifungal – Triazole

Highlight

• IDSA Recommendation for 1st line therapy invasive candidiasis
• More effective than fluconazole in preventing fungal infection in patients undergoing a bone marrow transplant

Indication

Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis & Abscesses Candidiasis Esofagus, Profilaksis for patient candidiasis with stem cell Transplantation.

Specification:

• Form: Lyophilized powder for injection
• Strength: 50 mg
• Pack: Box, 1 Vial
• REG. BPOM: DKI2161900180A1
• Halal: Porcine-free (Halal certificate not yet available)
• Approvals: IDSA recommended (1st-line)